Ameriprise’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-42,003
| Closed | -$2.86M | – | 4120 |
|
|
2022
Q3 | $2.86M | Buy |
+42,003
| New | +$2.32M | ﹤0.01% | 2603 |
|
|
2022
Q2 | – | Sell |
-13,559
| Closed | -$470K | – | 4033 |
|
|
2022
Q1 | $470K | Sell |
13,559
-21,846
| -62% | -$653K | ﹤0.01% | 3510 |
|
|
2021
Q4 | $1.04M | Buy |
+35,405
| New | +$1.1M | ﹤0.01% | 3237 |
|
|
2021
Q3 | – | Sell |
-15,028
| Closed | -$526K | – | 3995 |
|
|
2021
Q2 | $526K | Sell |
15,028
-17,382
| -54% | -$679K | ﹤0.01% | 3443 |
|
|
2021
Q1 | $1.32M | Sell |
32,410
-2,399
| -7% | -$110K | ﹤0.01% | 3023 |
|
|
2020
Q4 | $1.51M | Buy |
34,809
+10,441
| +43% | +$515K | ﹤0.01% | 2911 |
|
|
2020
Q3 | $1.34M | Sell |
24,368
-40,115
| -62% | -$2.55M | ﹤0.01% | 2854 |
|
|
2020
Q2 | $4.07M | Buy |
64,483
+40,058
| +164% | +$2.75M | ﹤0.01% | 2207 |
|
|
2020
Q1 | $1.25M | Sell |
24,425
-6,052
| -20% | -$405K | ﹤0.01% | 2723 |
|
|
2019
Q4 | $2.42M | Buy |
30,477
+7,456
| +32% | +$442K | ﹤0.01% | 2633 |
|
|
2019
Q3 | $1.12M | Buy |
23,021
+2,440
| +12% | +$127K | ﹤0.01% | 2981 |
|
|
2019
Q2 | $1.08M | Sell |
20,581
-119
| -0.6% | -$6.84K | ﹤0.01% | 3032 |
|
|
2019
Q1 | $1.09M | Buy |
20,700
+9,214
| +80% | +$453K | ﹤0.01% | 2997 |
|
|
2018
Q4 | $470K | Buy |
+11,486
| New | +$430K | ﹤0.01% | 3208 |
|
|
2018
Q3 | – | Sell |
-49,303
| Closed | -$2.23M | – | 3803 |
|
|
2018
Q2 | $2.23M | Sell |
49,303
-25,699
| -34% | -$1.17M | ﹤0.01% | 2693 |
|
|
2018
Q1 | $3.62M | Buy |
75,002
+43,503
| +138% | +$2.43M | ﹤0.01% | 2399 |
|
|
2017
Q4 | $1.24M | Sell |
31,499
-9,627
| -23% | -$360K | ﹤0.01% | 2880 |
|
|
2017
Q3 | $1.28M | Buy |
41,126
+402
| +1% | +$11.3K | ﹤0.01% | 2854 |
|
|
2017
Q2 | $1.11M | Sell |
40,724
-248
| -0.6% | -$7.38K | ﹤0.01% | 2897 |
|
|
2017
Q1 | $1.51M | Buy |
+40,972
| New | +$1.03M | ﹤0.01% | 2705 |
|
Other funds holding GBT
Ameriprise's GBT Position: Q4 2022 in Review
Ameriprise sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 42,003 shares — an estimated $2.86M sold.
Ameriprise first reported a position in GBT in Q1 2017 and held it in 20 quarters. The position peaked at $4.07M in Q2 2020. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Ameriprise reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Ameriprise sold 42,003 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $2.86M.
- Ameriprise first reported a position in Global Blood Therapeutics, Inc. in Q1 2017 and held it in 20 quarters.
- Ameriprise's Global Blood Therapeutics, Inc. position peaked at $4.07M in Q2 2020.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.